Directed Enzyme Prodrug Therapies
作者： Dan Niculescu-Duvaz , Gabriel Negoita-Giras , Ion Niculescu-Duvaz , Douglas Hedley , Caroline J. Springer
DOI: 10.1002/9783527633166.CH12
关键词:
摘要:
sci-hub.se 参考文章(375)
C. J. Springer, I. Niculescu-Duvaz, Antibody-directed enzyme prodrug therapy (ADEPT) : a targeting strategy in cancer chemotherapy Current Medicinal Chemistry. ,vol. 2, pp. 687- 706 ,(1995)
Bisset Gm, Pedley Rb, Jackman Al, Springer Cj, Marshall D, Boyle Ft, Bavetsias, Prodrugs of thymidylate synthase inhibitors: potential for antibody directed enzyme prodrug therapy (ADEPT). Anti-cancer Drug Design. ,vol. 11, pp. 625- 636 ,(1996)
Connors Ta, The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. Gene Therapy. ,vol. 2, pp. 702- ,(1995)
A J Giaccia, M L Mauchline, T O Davis, N P Minton, J M Brown, M E Fox, M J Lemmon, Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia Gene Therapy. ,vol. 3, pp. 173- 178 ,(1996)
J A Boden, G T Rogers, S K Sharma, R G Melton, P Antoniw, K D Bagshawe, R F Sherwood, C J Springer, P J Burke, Antibody directed enzyme prodrug therapy (ADEPT): clinical report. Disease Markers. ,vol. 9, pp. 233- 238 ,(1991)
Weedon Sj, McNeish Ia, Grove Ji, Searle Pf, Green Nk, Kerr Dj, Virus-directed enzyme prodrug therapy using CB1954. Anti-cancer Drug Design. ,vol. 14, pp. 461- 472 ,(1999)
Hironobu Tatsuo, Nobuyuki Ono, Kotaro Tanaka, Yusuke Yanagi, 麻疹ウイルスレセプター: SLAM (CDw150) Uirusu. ,vol. 50, pp. 289- 296 ,(2000) , 10.2222/JSV.50.289
Enzyme-prodrug strategies for cancer therapy Kluwer Academic/Plenum Publishers. ,(1999) , 10.1007/978-1-4615-4823-2
C Cunningham, J Nemunaitis, A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001. Human Gene Therapy. ,vol. 12, pp. 1594- 1596 ,(2001)
Peter D. Senter, Paul G. Grothaus, Gary S. Bignami, Tom Humphreys, Keith J. Fischer, Philip M. Wallace, N-(4′-Hydroxyphenylacetyl)palytoxin: A Palytoxin Prodrug That Can Be Activated by a Monoclonal Antibody-Penicillin G Amidase Conjugate Cancer Research. ,vol. 52, pp. 5759- 5764 ,(1992)